STOCK TITAN
  1. Home
  2. Sec-filings
  3. IVP
  4. [8-K] INSPIRE VETERINARY PARTNERS, INC. Reports Material Event

Director Erinn Thomas-Mackey exits Inspire Veterinary Partners (IVP) board

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Inspire Veterinary Partners, Inc. reported that director Erinn Thomas-Mackey resigned from its board of directors, effective immediately on February 26, 2026. The company stated that her resignation was not related to any disagreement regarding its operations, policies, or practices.

The update focuses solely on this board change and confirms that she did not raise disputes about how the business is being run.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Understanding 8-K Material Events →
false 0001939365 0001939365 2026-03-02 2026-03-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report: March 2, 2026

 

INSPIRE VETERINARY PARTNERS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41792   85-4359258
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
of incorporation)       Identification No.)

 

780 Lynnhaven Parkway, Suite 400
Virginia Beach, VA		   23452
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (757) 734-5464

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.0001   IVP   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 26, 2026, Erinn Thomas-Mackey notified the board of directors (the “Board”) of Inspire Veterinary Partners Inc. (the “Company”) of her resignation from the Board, effective immediately. The resignation of Ms. Thomas-Mackey as a director was not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 2, 2026 INSPIRE VETERINARY PARTNERS, INC.
   
  By: /s/ Kimball Carr
  Name:  Kimball Carr
  Title: President and Chief Executive Officer

 

2

Source: View Original Filing on SEC EDGAR

FAQ

What board change did Inspire Veterinary Partners (IVP) disclose in this 8-K?

Inspire Veterinary Partners disclosed that director Erinn Thomas-Mackey resigned from its board, effective February 26, 2026. The company emphasized that her departure was not due to any disagreement over operations, policies, or practices, indicating a routine governance change rather than a conflict-driven exit.

Did Erinn Thomas-Mackey cite any disagreement with Inspire Veterinary Partners (IVP)?

No, the company stated that Erinn Thomas-Mackey’s resignation was not related to any disagreement with Inspire Veterinary Partners. Specifically, there were no disputes disclosed about the company’s operations, policies, or practices, suggesting an amicable and non-controversial transition from the board.

When did Erinn Thomas-Mackey’s resignation from Inspire Veterinary Partners’ board become effective?

Her resignation became effective immediately on February 26, 2026. Inspire Veterinary Partners reported that she notified the board on that date, and the effectiveness was immediate, meaning she no longer served as a director from that day forward, according to the company’s disclosure language.

Which SEC item does Inspire Veterinary Partners use to report this board resignation?

Inspire Veterinary Partners reported the resignation under Item 5.02, which covers departures of directors or certain officers and related arrangements. This item is used to inform investors about key leadership or governance changes that may be important to understanding the company’s management structure.

Who signed the Inspire Veterinary Partners (IVP) 8-K reporting the director’s resignation?

The 8-K was signed by Kimball Carr, who is identified as the company’s President and Chief Executive Officer. His signature indicates the filing was authorized at the executive level, as required for reports submitted under the Securities Exchange Act of 1934.

Filing Exhibits & Attachments

3 documents

Other Documents